Reinfection clinical trials
The registry lists 35 studies for Reinfection across more than 10 countries. 6 are recruiting or about to start. 5 of them are mainly about Reinfection (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.
Get an email when these change. Save the Reinfection studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
National Taiwan University Hospital (3) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Peking University (1) · National Jewish Health (1) · University Medical Centre Ljubljana (1) · Magdalena Salcedo (1) · Instituto Grifols, S.A. (1) · Boston Medical Center (1)
What is being tested here
Drugs under test in Reinfection studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 3
- Dec 2026Clinicaly Manifested Reinfections with Borrelia Burgdorferi Sensu Lato · University Medical Centre Ljubljana
- Mar 2027STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection · Medical University of Warsaw
- Jun 2027Probiotics in the Prevention of Recurrent Prosthetic Joint Infection of the Hip and Knee · Boston Medical Center
Who these studies take
Of the 3 Reinfection studies recruiting now, 2 (67%) set no upper age limit and 0 (0%) stop at 75 or younger. 2 (67%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (33%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (67%) | 2 (67%) |
| 18 | 3 (100%) | 3 (100%) |
| 30 | 3 (100%) | 3 (100%) |
| 40 | 3 (100%) | 3 (100%) |
| 50 | 3 (100%) | 3 (100%) |
| 65 | 3 (100%) | 3 (100%) |
| 75 | 3 (100%) | 3 (100%) |
| 85 | 3 (100%) | 3 (100%) |
Across all 35 studies, recruiting or not: 26% stop at 75 or younger and 9% at 65; 29% take children; 0% are for women only and 3% for men only; 17% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 35 of 35. search them.
- Detection and Characterization of Infections and Infection SusceptibilityRecruitingNCT004045601 country
- Evaluation of Patients With Immune Function AbnormalitiesRecruitingNCT001289731 country
- Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk PatientsRecruitingNCT06306014Phase 1/21 country
- Probiotics in the Prevention of Recurrent Prosthetic Joint Infection of the Hip and KneeEnrolling by invitationNCT06636669Phase 41 country
- STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile InfectionNot yet recruitingNCT07120490Not applicable
- Fecal Filtrate as a Treatment Option of Multiple Recurrent Clostridioides Difficile InfectionNot yet recruitingNCT04960306Phase 31 country
- Study to Evaluate H56:IC31 in Preventing Rate of TB RecurrenceCompletedNCT03512249Phase 22 countries
- Reinfection and Re-revision Rates of Periprosthetic Knee Infection Under Four Different Surgical StrategiesCompletedNCT072327711 country
- Nettle and Cranberry Capsules for Prevention of Urinary Tract InfectionCompletedNCT05880602Not applicable1 country
- Clinicaly Manifested Reinfections with Borrelia Burgdorferi Sensu LatoActive, not recruitingNCT068350751 country
- Long COVID and Its Associations With Health Outcomes in Older AdultsActive, not recruitingNCT058256511 country
- Patient-Centered Models of HCV Care for People Who Inject DrugsCompletedNCT02824640Not applicable1 country
- Interventions to Curb Hepatitis C Reinfections Among Men Who Have Sex With MenStatus unknownNCT04156945Not applicable2 countries
- Characteristics of SARS-CoV-2 ReinfectionStatus unknownNCT057482621 country
- Direct-acting Antiviral Therapy and Reinfection Among PWID With Chronic HCV in Community-based SettingsCompletedNCT033439251 country
- Comparison of Efficacy of Two Combination Regimens for the Neisseria Gonorrhoeae and Chlamydia CoinfectionCompletedNCT05216744Phase 21 country
- RT-PCR Database Analysis for COVID-19 Infections and Re-infectionStatus unknownNCT046538441 country
- Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDsCompletedNCT03127358Not applicable1 country
- A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus InfectionStatus unknownNCT04966234Phase 2/311 countries
- HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral TherapyStatus unknownNCT047685171 country
- HCV Reinfection in HD Patients Achieving SVRStatus unknownNCT047328321 country
- MET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI)CompletedNCT02865616Phase 11 country
- Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent PatientsStatus unknownNCT044104711 country
- The Situation of Re-infection of Helicobacter Pylori After Successful EradicationStatus unknownNCT040294931 country
- Prosthetic Hip Infections: Prospective StudyCompletedNCT019635201 country
- Pneumococcal Post-Vaccination TitersStatus unknownNCT02726347Not applicable1 country
- Catheter Salvage in Intestinal Failure PatientsCompletedNCT032222321 country
- Investigation of Immune Disorders and DeficienciesStatus unknownNCT019817851 country
- Antibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by EnterobacteriaceaeCompletedNCT02400268Phase 31 country
- Prevention of Recurrent Infections Caused by Community Acquired Staphylococcus Aureus (CA-SA) in ChildrenCompletedNCT00901316Not applicable1 country
- Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant RecipientsCompletedNCT01131065Phase 31 country
- Reinfection After Eradication of Helicobacter Pylori InfectionStatus unknownNCT026748021 country
- Exogenous Reinfection of Tuberculosis in TaiwanCompletedNCT001734331 country
- Effect of Dental Scaling on Helicobacter Pylori Eradication and ReinfectionStatus unknownNCT018162691 country
- Evaluate Bacteriophage as a Useful Immunogen in Patients With Primary Immune Deficiency Diseases (PIDD)Status unknownNCT01617122Not applicable1 country